Furthermore, 18F-THK-5351 PET can potentially be used to detect the regional tau distribution in brain regions in PSP, and therefore this novel radiopharmaceutical may potentially support the differential diagnosis of neurodegenerative disorders associated with tau protein. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.